QuidelOrtho Corp. (QDEL), a medical devices company, Wednesday announced that it has terminated its Chief Executive Officer and President Douglas Bryant after a comprehensive evaluation.
Michael Iskra the current chief commercial officer will be replacing Bryant in the interim period and Robert Bujarski, the current chief operating officer will be the interim president, effective February 21.
The company is on a search for a new chief executive and maintains its financial guidance provided on February 16.
In pre-market activity, QuidelOrtho shares are trading at $46.01, down 1.24% on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.